Trial Profile
A single institution, biomarker trial to study association of biomarkers with cardiac events during abiraterone acetate treatment in patients with castration-resistant prostate.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Canrenone; Dexamethasone; Prednisone
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 02 Sep 2015 New trial record